10-95336853-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001034954.3(SORBS1):c.3307G>A(p.Val1103Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000502 in 1,614,060 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001034954.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SORBS1 | NM_001034954.3 | c.3307G>A | p.Val1103Ile | missense_variant | 30/33 | ENST00000371247.7 | NP_001030126.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SORBS1 | ENST00000371247.7 | c.3307G>A | p.Val1103Ile | missense_variant | 30/33 | 5 | NM_001034954.3 | ENSP00000360293 | P3 |
Frequencies
GnomAD3 genomes AF: 0.000269 AC: 41AN: 152192Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000128 AC: 32AN: 250818Hom.: 0 AF XY: 0.0000885 AC XY: 12AN XY: 135592
GnomAD4 exome AF: 0.0000274 AC: 40AN: 1461868Hom.: 0 Cov.: 32 AF XY: 0.0000193 AC XY: 14AN XY: 727244
GnomAD4 genome AF: 0.000269 AC: 41AN: 152192Hom.: 0 Cov.: 32 AF XY: 0.000350 AC XY: 26AN XY: 74352
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 20, 2023 | The c.3307G>A (p.V1103I) alteration is located in exon 28 (coding exon 28) of the SORBS1 gene. This alteration results from a G to A substitution at nucleotide position 3307, causing the valine (V) at amino acid position 1103 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at